Altus Biologics

04/29/2026

Several factors can contribute to cognitive issues in people with multiple sclerosis, including low blood sugar, certain medications, depression, stress, and fatigue.

04/27/2026

Launching or expanding an in-office infusion program means 🏥 building the operational, clinical, and financial infrastructure to support safe, efficient, and sustainable care.

Practices that plan early for staffing, workflows, reimbursement, and patient access 🔀 are often better positioned to scale with less friction.

Key Considerations When Launching or Expanding an In-Office Infusion Program. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

04/24/2026

Crohn’s disease can develop at any age, but it is most often diagnosed between ages 20 and 30.

04/22/2026

🌟 Today, on National Administrative Professionals Day, Altus Biologics is proud to recognize the incredible administrative professionals who help keep our team running smoothly every day.

A special thank you to Pat Richards, Administrative Assistant, and Sonia Wootton, Sr. Executive Assistant, for all they do to support our organization. Their attention to detail and behind-the-scenes contributions play an essential role in helping Altus Biologics serve providers and patients with excellence. 👏

We’re grateful for the hard work and care they bring to Altus Biologics each day. Thank you, Pat and Sonia, for everything you do!

04/21/2026

Managing stress may help reduce lupus flare-ups.

04/20/2026

Behind every timely diagnosis and treatment decision is a team whose precision and expertise help keep patient care moving forward. 🕑

This 🔬 Medical Laboratory Professionals Week, Altus Biologics is recognizing the medical laboratory professionals whose work supports providers, informs care decisions, and helps improve outcomes for patients living with chronic conditions.

To every medical laboratory professional, thank you for the care, accuracy, and dedication you bring to patients every day. 🧪

04/16/2026

IBS is a functional digestive disorder, while IBD is an inflammatory disease that can damage the digestive tract.

💬 That difference matters because it affects diagnosis, treatment, and whether biologic therapy may be part of the conversation.

👉 Read more:

IBS vs. IBD: What’s the Difference, and When Could Biologic Treatment Be Part of the Conversation?. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

04/15/2026

Stress management plays an important role in supporting both emotional wellness and overall health when living with multiple sclerosis.

04/14/2026

‘There’s still something we are missing’: Biologics underused in multinational survey.

PHILADELPHIA — Less than 15% of adults with uncontrolled asthma eligible for biologic therapy reported current biologic use, according to survey data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Biologics have been around for 40 years, so there&rs...

04/10/2026

The FDA’s recent push to streamline biosimilar development may look like a manufacturer-side story at first glance, but it has real downstream 🔁 effects for infusion practices.

What FDA’s New Biosimilar Development Push Could Mean for Infusion Practices in 2026. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

04/10/2026

Although genetics can raise the risk of IBD, family history alone cannot predict who will develop Crohn’s disease.